Lack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greece

Απλή σελίδα τεκμηρίου
dc.contributor.authorZalavras Ch, G.en
dc.contributor.authorGiotopoulou, S.en
dc.contributor.authorDokou, E.en
dc.contributor.authorMitsis, M.en
dc.contributor.authorIoannou, H. V.en
dc.contributor.authorTzolou, A.en
dc.contributor.authorKolaitis, N.en
dc.contributor.authorVartholomatos, G.en
dc.date.accessioned2015-11-24T19:08:23Z
dc.date.available2015-11-24T19:08:23Z
dc.identifier.issn0392-9590-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20523
dc.rightsDefault Licence-
dc.subject5,10-Methylenetetrahydrofolate Reductase (FADH2)en
dc.subjectAdulten
dc.subjectDNA Mutational Analysisen
dc.subjectGene Frequency/geneticsen
dc.subjectGenetic Predisposition to Disease/geneticsen
dc.subjectGreeceen
dc.subjectHomozygoteen
dc.subjectHumansen
dc.subjectHyperhomocysteinemia/complications/*geneticsen
dc.subjectMethylenetetrahydrofolate Reductase (NADPH2)en
dc.subjectMutation/*geneticsen
dc.subjectOdds Ratioen
dc.subjectOxidoreductases/*geneticsen
dc.subjectPolymorphism, Genetic/geneticsen
dc.subjectThromboembolism/etiology/*geneticsen
dc.subjectVenous Thrombosis/etiology/*geneticsen
dc.titleLack of association between the C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene and venous thromboembolism in Northwestern Greeceen
heal.abstractBACKGROUND: Hyperhomocysteinemia has been associated with venous thrombosis. Under known and unknown conditions the C677T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene is accompanied by elevated levels of homocysteine. However, the relationship of this mutation with venous thromboembolism (VTE) remains controversial. The purpose of this study was to evaluate the association of the MTHFR mutation with VTE. METHODS: The presence of the C677T mutation in the MTHFR gene was investigated in a population of 176 consecutive patients with a history of venous thromboembolism and in a control group of 300 healthy subjects, using DNA analysis. RESULTS: The prevalence of homozygosity in the patient group was 13.6% and in healthy subjects 10%. The odds ratio for venous thromboembolism in the presence of the homozygous genotype (677TT) was 1.4 (95% confidence interval (C.I.), 0.8 to 2.5), which was not statistically significant. CONCLUSIONS: Homozygosity for the T677 allele of the MTHFR gene, although slightly more prevalent in patients compared to controls, has not been found in association with venous thromboembolism.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/12384649-
heal.journalNameInt Angiolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2002-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ